Lane to lead product and engineering strategy, driving innovation and growth in AI-powered real-world evidence and outcomes solutions for healthcare
OM1, the leader in real-world evidence (RWE) generation and AI-driven insights for healthcare and life sciences, announced the appointment of Hunter Lane as Chief Product Officer. In this role, Lane will lead the company’s Product and Engineering teams, overseeing the development and delivery of OM1’s rapidly growing portfolio of AI-driven evidence and outcomes solutions.
“Hunter’s track record of building category-defining platforms and delivering impact at scale makes him an ideal leader for our next stage of growth,” said Dr. Richard Gliklich, CEO and Founder of OM1. “His experience integrating AI and real-world data into clinical and research workflows aligns with OM1’s mission to improve health outcomes and accelerate innovation.”
Also Read: Turbine & MSD Use AI to Simulate Hard-to-Treat Cancers
Lane brings deep experience in health data innovation and product strategy, having most recently served as Senior Director of Product at Tempus AI. There, he launched the company’s flagship platform and was instrumental in scaling its genomics business from pre-revenue to $452 million in annual revenue. Under his leadership, Tempus built one of the largest real-world oncology datasets, driving research across 95% of the top 20 pharmaceutical companies.
“OM1 is uniquely positioned at the intersection of real-world data, AI, and patient outcomes,” said Lane. “I’m thrilled to join this exceptional team and help scale the next generation of solutions that will power smarter research, more equitable care, and better results for patients everywhere.”
Source: Businesswire
